Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 2, 2009, Pages 505-518

  Zhao, Haizheng ^a   Yung, Lin Yue Lanry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Drug delivery; Folate; PLGA; Polymer micelle; Targeting; TPGS

Indexed keywords

FOLATE; PLGA; POLYMER MICELLE; TARGETING; TPGS;

CELL CULTURE; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; ENCAPSULATION; ENZYME INHIBITION; ETHYLENE; ETHYLENE GLYCOL; FUNCTIONAL POLYMERS; GLYCOPROTEINS; ORGANIC POLYMERS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERS;

MICELLES;

DOXORUBICIN; FOLATE RECEPTOR; FOLIC ACID; GLYCOPROTEIN P; MACROGOL; POLYGLACTIN; RHODAMINE; TOCOFERSOLAN;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; FIBROBLAST; HUMAN; HUMAN CELL; MICELLE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FOLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTIC ACID; MICELLES; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RECEPTORS, CELL SURFACE; RHODAMINES; VITAMIN E;

EID: 70349440850     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32220     Document Type: Article

References (57)

1. Lu JY, Low PS. Immunotherapy of folate receptor-expressing tumors: Review of recent advances and future prospects. J Control Release 2003;91:17-29. (Pubitemid 37303991)
2. Ke CY, Mathias CJ, Green MA. The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nucl Med Biol 2003;30:811-817.
3. Lu JY, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002;54:675-693. (Pubitemid 35247522)
4. Lu JY, Sega E, Leamon CP, Low PS. Folate receptor-targeted immunotherapy of cancer: Mechanism and therapeutic potential. Adv Drug Deliv Rev 2004;56:1161-1176. (Pubitemid 38496513)
5. Leamon CP, Cooper SR, Hardee GE. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: Evaluation in vitro and in vivo. Bioconjug Chem 2003;14:738-747.
6. Leamon CP, Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev 2004;56:1127-1141.
7. Ward CM, Acheson N, Seymour LM. Folic acid targeting of protein conjugates into ascites tumor cells from ovarian cancer patients. J Drug Target 2000;8:119-123. (Pubitemid 30336131)
8. Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly(caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005;26:1053-1061.
9. Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst 2005;1:242-250. (Pubitemid 41442434)
10. Kim SH, Jeong JH, Joe CO, Park TG. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Release 2005;103:625-634.
11. Park EK, Kim SY, Lee SB, Lee YM. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release 2005;109:158-168.
12. Jones M, Leroux J. Polymeric micelles - A new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999;48:101-111. (Pubitemid 29401986)
13. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001;73:137-172. (Pubitemid 32544594)
14. Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 2002;54:235-252.
15. Torchillin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: Targetted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003;100:6039-6044. (Pubitemid 36576927)
16. Mu L, Seow PH. Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B: Biointerfaces 2006;47:90-97. (Pubitemid 43111610)
17. Youk HJ, Lee E, Choi MK, Lee YJ, Chung JH. Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release 2005;107:43-52. (Pubitemid 41253701)
18. Varma MVS, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005;25:445-453. (Pubitemid 40853872)
19. Sparreboom A, Asperen JV, Mayer U, Schinkel AH, Smit JW, Meijer DKF. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 1997;4:2031-2035. (Pubitemid 27113956)
20. Bardelmeijer HA, Beijnen JH, Brouwer KR, Rosing H, Nooijen WJ, Schellens JHM. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein. Clin Cancer Res 2000;6:4416-4421. (Pubitemid 30840197)
21. Bogman K, Zysset Y, Degen L, Hopfgartner G, Gutmann H, Alsenz J. P-glycoprotein and surfactants: Effect on intestinal talinolol absorption. Clin Pharmacol Ther 2005;77:24-32. (Pubitemid 40075386)
22. Feng SS, Huang GF. Effect of emulsifiers on the controlled release of paclitaxel from nanospheres of biodegradable polymers. J Control Release 2001;1:53-69. (Pubitemid 32195441)
23. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel. J Control Release 2002;80:129-144. (Pubitemid 34273754)
24. Kea WT, Linb SY, Hoa HO, Sheu MT. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. J Control Release 2005;102:489-507.
25. Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005;306:142-149. (Pubitemid 41643148)
26. Zhao HZ, Yung LYL. Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm 2008;349:256-268.
27. Johnson BM, Charman WN. An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS Pharm Sci 2002;4:E40.
28. Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004;278:119-131. (Pubitemid 38670443)
29. Wang SW, Monagle J, McNulty C, Putnam D, Chen H. Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughtput process. J Pharm Sci 2004;93:2755-2767. (Pubitemid 39506626)
30. Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004;96:273-283.
31. Missirlis D, Kawamura R, Tirelli N, Hubbell JA. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci 2006;29:120-129. (Pubitemid 44332885)
32. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994;269:3198-3204. (Pubitemid 24237629)
33. Choi Y, Thomas T, Kotlyer A, Islam MT, Baker JR. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol 2005;12:35-43. (Pubitemid 40118324)
34. Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 2005;103:405-418. (Pubitemid 40342538)
35. Lee RT, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995;1233:134-144.
36. Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 2003;91:103-113. (Pubitemid 37288881)
37. Win KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 2006;27:2285-2291.
38. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 1999;16:3-27. (Pubitemid 29486794)
39. Sugawara T, Kinoshita M, Ohnishi M, Tsuzuki T, Miyazawa T, Nagata J, Hirata T, Saito M. Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells. Biosci Biotechnol Biochem 2004;68:2541-2546. (Pubitemid 40218184)
40. Lo YL, Hsu CY, Huang JD. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res 1998;18:3005-3009.
41. Ouar Z, Lacave R, Bens M, Vandewalle A. Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells. Cell Biol Toxicol 1999;15:91-100. (Pubitemid 29277504)
42. Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 1997;40:13-19. (Pubitemid 127709569)
43. Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther Drug Monit 2000;22:137-140.
44. Rgev R, Katzir H, Yeheskely-Hayon D, Eytan GD. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane. FEBS J 2007;274:6204-6214. (Pubitemid 350135339)
45. Yu L, Bridgers A, Polli J, Vickers A, Long, S. Vitamin E TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. J Pharm Res 1999;16:1812-1817. (Pubitemid 30040695)
46. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-1556.
47. Collnot EM, Baldes C, Wempe MF, Kappl R, Hüttermann J, Hyatt JA, Edgar KJ, Schaefer UF, Lehr CM. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidity. Mol Pharm 2007;4:465-474. (Pubitemid 46983960)
48. Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, Schaefer UF, Lehr CM. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in caco-2 cell monolayers. J Control Release 2006;111:35-40. (Pubitemid 43289992)
49. Yamagata T, Kusuhara H, Morishita M, Takayama K, Benameur H, Sugiyama Y. Effect of excipients on breast cancer resistance protein substrate uptake activity. J Control Release 2007;124:1-5. (Pubitemid 350088212)
50. Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporine absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991;338:212-214.
51. Boudreaux JP, Hayes DH, Mizrahi S, Maggiore P, Blazek J, Dick D. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant Proc 1993;25:1875. (Pubitemid 23125129)
52. Yamagata T, Kusuhara H, Morishita M, Takayama K, Benameur H, Sugiyama Y. Effect of excipients on breast cancer resistance protein substrate uptake activity. J Control Release 2007;124:1-5. (Pubitemid 350088212)
53. Rubeai A, Singh RP. Apoptosis in cell culture. Curr Opin Biotechnol 1998;9:152-156.
54. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420. (Pubitemid 24273007)
55. Engeland V, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996;24:131-139. (Pubitemid 26202924)
56. Wang XF, Witting PK, Salvatore BA, Neuzil J. Vitamin E analogs trigger apoptosis in HER2/erbB2 - Ovexpressing breast cancer cells by signaling via mitochondrial pathway. Biochem Biophys Res Commun 2005;326:282-289. (Pubitemid 39593544)
57. Allva R, Benassi MS, Pazzaglia L, Tomasetti M, Gellert N. Tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis. Cancer Lett 2006;232:226-235. (Pubitemid 43170972)